{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T07:39:14Z","timestamp":1781077154127,"version":"3.54.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":139,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100011055","name":"ASH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1053\/j.seminhematol.2026.04.004","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T05:09:03Z","timestamp":1776575343000},"page":"521-531","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diagnosis and management of telomere biology disorders in developing countries"],"prefix":"10.1053","volume":"62","author":[{"given":"Alfredo","family":"Rodr\u00edguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda A.","family":"Avenda\u00f1o-Robles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilia B.","family":"Catto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Ju\u00e1rez-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo T.","family":"Calado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0001","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41525-021-00198-5","article-title":"Telomere biology disorders","volume":"6","author":"Kam","year":"2021","journal-title":"NPJ Genomic Med"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0002","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1167848","article-title":"Telomere biology: from disorders to hematological diseases","volume":"13","author":"Roka","year":"2023","journal-title":"Front Oncol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0003","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13053-023-00251-7","article-title":"Size matters in telomere biology disorders \u2012 expanding phenotypic spectrum in patients with long or short telomeres","volume":"21","author":"Byrjalsen","year":"2023","journal-title":"Hered Cancer Clin Pract"},{"issue":"19","key":"10.1053\/j.seminhematol.2026.04.004_bib0004","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1182\/bloodadvances.2020001721","article-title":"Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and\/or pulmonary presentations","volume":"4","author":"Feurstein","year":"2020","journal-title":"Blood Adv"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.04.004_bib0005","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1182\/bloodadvances.2021004345","article-title":"Approach to the diagnosis of aplastic anemia","volume":"5","author":"DeZern","year":"2021","journal-title":"Blood Adv"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0006","first-page":"157","article-title":"The diagnosis and treatment of dyskeratosis congenita: a review","volume":"5","author":"Fern\u00e1ndez Garc\u00eda","year":"2014","journal-title":"J Blood Med"},{"issue":"1190","key":"10.1053\/j.seminhematol.2026.04.004_bib0007","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/postmj\/qgae102","article-title":"Telomere biology disorders: from dyskeratosis congenita and beyond","volume":"100","author":"Roka","year":"2024","journal-title":"Postgrad Med J"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-226736","article-title":"Dyskeratosis congenita: presentation of cutaneous triad in a sporadic case","volume":"11","author":"Sharma","year":"2018","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0009","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.949435","article-title":"Fanconi anemia and dyskeratosis congenita\/telomere biology disorders: two inherited bone marrow failure syndromes with genomic instability","volume":"12","author":"Fiesco-Roa","year":"2022","journal-title":"Front Oncol"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.004_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/bjh.13442","article-title":"Unraveling the pathogenesis of Hoyeraal-Hreidarsson syndrome, a complex telomere biology disorder","volume":"170","author":"Glousker","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0011","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ajo.2025.03.027","article-title":"Telomere biology disorders: microvascular abnormalities on optical coherence tomography","volume":"275","author":"DA Cruz","year":"2025","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.004_bib0012","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1111\/ceo.14494","article-title":"Hereditary vitreoretinopathies: molecular diagnosis, clinical presentation and management","volume":"53","author":"Ghoraba","year":"2025","journal-title":"Clin Experiment Ophthalmol"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.04.004_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50111","article-title":"Genotype and associated cancer risk in individuals with telomere biology disorders","volume":"7","author":"Niewisch","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0014","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/s13023-020-01553-y","article-title":"Revesz syndrome revisited","volume":"15","author":"Karremann","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0015","article-title":"Coats plus syndrome with new observation of drusenoid retinal pigment epithelial detachments in a teenager","volume":"28","author":"Agrawal","year":"2022","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0016","article-title":"Inherited bone marrow failure syndromes: phenotype as a tool for early diagnostic suspicion at a major reference center in Mexico","volume":"14","author":"Leal-Anaya","year":"2023","journal-title":"Front Genet"},{"issue":"21","key":"10.1053\/j.seminhematol.2026.04.004_bib0017","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1182\/blood.V124.21.1605.1605","article-title":"Better performance of flow-FISH in comparison to qPCR As a diagnostic test for Telomere diseases","volume":"124","author":"Gutierrez-Rodrigues","year":"2014","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0018","first-page":"876","article-title":"Genetic determination of telomere size in humans: a twin study of three age groups","volume":"55","author":"Slagboom","year":"1994","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.004_bib0019","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.tig.2023.10.013","article-title":"Genome stability from the perspective of telomere length","volume":"40","author":"Lu","year":"2024","journal-title":"Trends Genet"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.004_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.hoc.2009.01.003","article-title":"Dyskeratosis congenita","volume":"23","author":"Savage","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0021","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1182\/blood-2007-02-075598","article-title":"Very short telomere length by flow fluorescence in situ hybridization identifies patients with dyskeratosis congenita","volume":"110","author":"Alter","year":"2007","journal-title":"Blood"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.04.004_bib0022","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nrg3246","article-title":"The telomere syndromes","volume":"13","author":"Armanios","year":"2012","journal-title":"Nat Rev Genet"},{"issue":"6274","key":"10.1053\/j.seminhematol.2026.04.004_bib0023","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/345458a0","article-title":"Telomeres shorten during ageing of human fibroblasts","volume":"345","author":"Harley","year":"1990","journal-title":"Nature"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.04.004_bib0024","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.10.e47","article-title":"Telomere measurement by quantitative PCR","volume":"30","author":"Cawthon","year":"2002","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0025","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/nprot.2006.263","article-title":"Flow cytometry and FISH to measure the average length of telomeres (flow FISH)","volume":"1","author":"Baerlocher","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0026","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.csbj.2024.04.011","article-title":"Techniques for assessing telomere length: a methodological review","volume":"23","author":"Yu","year":"2024","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"10.1053\/j.seminhematol.2026.04.004_bib0027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0113747","article-title":"Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans","volume":"9","author":"Gutierrez-Rodrigues","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0028","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41467-023-35823-7","article-title":"High-throughput telomere length measurement at nucleotide resolution using the PacBio high fidelity sequencing platform","volume":"14","author":"Tham","year":"2023","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0029","doi-asserted-by":"crossref","first-page":"5148","DOI":"10.1038\/s41467-024-49007-4","article-title":"Digital telomere measurement by long-read sequencing distinguishes healthy aging from disease","volume":"15","author":"Sanchez","year":"2024","journal-title":"Nat Commun"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0030","series-title":"Telomere biology disorders diagnosis and management guidelines","first-page":"31","article-title":"Chapter 3: Diagnosing telomere biology disorders","author":"Bertuch","year":"2022"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0031","first-page":"59","article-title":"Telomere length measurement\u2014caveats and a critical assessment of the available technologies and tools","volume":"730","author":"Aubert","year":"2012","journal-title":"Mutat Res Mol Mech Mutagen"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.04.004_bib0032","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1038\/nprot.2010.124","article-title":"Measurement of telomere length by the southern blot analysis of terminal restriction fragment lengths","volume":"5","author":"Kimura","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0034","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.psyneuen.2018.10.005","article-title":"Telomere length measurement by qPCR \u2013 Summary of critical factors and recommendations for assay design","volume":"99","author":"Lin","year":"2019","journal-title":"Psychoneuroendocrinology"},{"issue":"16","key":"10.1053\/j.seminhematol.2026.04.004_bib0035","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1093\/nar\/26.16.3651","article-title":"Telomere analysis by fluorescence in situ hybridization and flow cytometry","volume":"26","author":"Hultdin","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0036","first-page":"385","article-title":"Telomere length measurement by fluorescence in situ hybridization and flow cytometry","volume":"263","author":"Kapoor","year":"2004","journal-title":"Methods Mol Biol Clifton NJ"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.04.004_bib0037","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1101\/gr.274639.120","article-title":"Haplotype diversity and sequence heterogeneity of human telomeres","volume":"31","author":"Grigorev","year":"2021","journal-title":"Genome Res"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.004_bib0038","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1101\/gr.275868.121","article-title":"Chromosome-specific telomere lengths and the minimal functional telomere revealed by nanopore sequencing","volume":"32","author":"Sholes","year":"2022","journal-title":"Genome Res"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0039","series-title":"GeneReviews\u00ae [Internet]","article-title":"Dyskeratosis congenita and related telomere biology disorders","author":"Savage","year":"1993-2026"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.04.004_bib0040","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1182\/blood.2024025023","article-title":"Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations","volume":"144","author":"Gutierrez-Rodrigues","year":"2024","journal-title":"Blood"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0041","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.3324\/haematol.2022.281808","article-title":"Effects of nandrolone decanoate on telomere length and clinical outcome in patients with telomeropathies: a prospective trial","volume":"108","author":"Cl\u00e9","year":"2023","journal-title":"Haematologica"},{"issue":"20","key":"10.1053\/j.seminhematol.2026.04.004_bib0042","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1056\/NEJMoa1515319","article-title":"Danazol treatment for Telomere diseases","volume":"374","author":"Townsley","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0043","unstructured":"Viva o SUS! O Maior Sistema P\u00fablico de Sa\u00fade Do Mundo \u00e9 Gratuito, Universal e Do Brasil (n.d.). https:\/\/www.gov.br\/saude\/pt-br\/assuntos\/noticias\/2025\/setembro\/viva-o-sus-o-maior-sistema-publico-de-saude-do-mundo-e-gratuito-universal-e-do-brasil [accessed 18.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0044","unstructured":"Comunicado Sobre o Desabastecimento de Danazol (Ladogal\u00ae) (n.d.). https:\/\/www.abhhoficial.com.br\/noticias\/comunicado-sobre-o-desabastecimento-de-danazol-ladogal-r [accessed 18.11.25]."},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.004_bib0045","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bjh.12748","article-title":"Response to androgen therapy in patients with dyskeratosis congenita","volume":"165","author":"Khincha","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0046","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/hematology.2023000490","article-title":"Clinical manifestations of telomere biology disorders in adults","volume":"2023","author":"Niewisch","year":"2023","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"7","key":"10.1053\/j.seminhematol.2026.04.004_bib0047","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.bbmt.2016.03.001","article-title":"Survival after hematopoietic stem cell transplant in patients with dyskeratosis congenita: systematic review of the literature","volume":"22","author":"Barbaro","year":"2016","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0048","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/bjh.15495","article-title":"Outcome of haematopoietic stem cell transplantation in dyskeratosis congenita","volume":"183","author":"Fioredda","year":"2018","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.004_bib0049","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.hemonc.2019.08.001","article-title":"Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): minimum requirements and beyond","volume":"13","author":"Pasquini","year":"2020","journal-title":"Hematol Oncol Stem Cell Ther"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3324\/haematol.2021.279189","article-title":"One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors","volume":"107","author":"Niederwieser","year":"2022","journal-title":"Haematologica"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0051","first-page":"1294","article-title":"Hematopoietic stem cell transplantation activity in Mexico during the COVID19 pandemic: on the way to recovery","volume":"27","author":"Le\u00f3n","year":"2022","journal-title":"Hematol Amst Neth"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.04.004_bib0052","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1590\/1413-81232022278.03142022","article-title":"Hematopoietic stem-cell transplants in Brazil: inequities in the distribution in Brazilian territory, 2001 to 2020]","volume":"27","author":"Magedanz","year":"2022","journal-title":"Cienc Saude Coletiva"},{"issue":"9396","key":"10.1053\/j.seminhematol.2026.04.004_bib0053","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/S0140-6736(03)14797-6","article-title":"Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA","volume":"362","author":"Fogarty","year":"2003","journal-title":"Lancet Lond Engl"},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0054","unstructured":"REDOME \u2013 Registro Brasileiro de Doadores Volunt\u00e1rios de Medula \u00d3ssea, (n.d.) https:\/\/redome.inca.gov.br\/ [accessed 18.11.25]."},{"key":"10.1053\/j.seminhematol.2026.04.004_bib0055","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.584950","article-title":"How ancestry influences the chances of finding unrelated donors: an investigation in admixed Brazilians","volume":"11","author":"Nunes","year":"2020","journal-title":"Front Immunol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0056","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/bmt.2015.352","article-title":"TCR \u03b1\u03b2 and CD19-depleted haploidentical stem cell transplant with reduced intensity conditioning for Hoyeraal-Hreidarsson syndrome with RTEL1 mutation","volume":"51","author":"Bhattacharyya","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"10.1053\/j.seminhematol.2026.04.004_bib0057","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/MPH.0000000000000283","article-title":"Successful T-cell-depleted haploidentical hematopoietic stem cell transplantation in a child with dyskeratosis congenita after a fludarabine-based conditioning regimen","volume":"37","author":"Algeri","year":"2015","journal-title":"J Pediatr Hematol Oncol"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.004_bib0058","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.bbmt.2016.11.006","article-title":"Haploidentical bone marrow transplantation with post-transplant cyclophosphamide for children and adolescents with Fanconi anemia","volume":"23","author":"Bonfim","year":"2017","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"12","key":"10.1053\/j.seminhematol.2026.04.004_bib0059","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1016\/j.bbmt.2020.09.007","article-title":"Impact of CD34 cell dose and conditioning regimen on outcomes after haploidentical donor hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for relapsed\/refractory severe aplastic anemia","volume":"26","author":"Arcuri","year":"2020","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.004_bib0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1399-3046.2010.01431.x","article-title":"Reduced-intensity conditioning for alternative donor hematopoietic stem cell transplantation in patients with dyskeratosis congenita","volume":"15","author":"Nishio","year":"2011","journal-title":"Pediatr Transplant"},{"issue":"1","key":"10.1053\/j.seminhematol.2026.04.004_bib0061","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/bmt.2010.65","article-title":"Disease-specific hematopoietic cell transplantation: nonmyeloablative conditioning regimen for dyskeratosis congenita","volume":"46","author":"Dietz","year":"2011","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1053\/j.seminhematol.2026.04.004_bib0062","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29177","article-title":"Reduced-intensity conditioning-based hematopoietic cell transplantation for dyskeratosis congenita: single-center experience and literature review","volume":"68","author":"Bhoopalan","year":"2021","journal-title":"Pediatr Blood Cancer"},{"issue":"3","key":"10.1053\/j.seminhematol.2026.04.004_bib0063","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/ejh.14023","article-title":"Hematopoietic cell transplantation for telomere biology diseases: a retrospective single-center cohort study","volume":"111","author":"Nichele","year":"2023","journal-title":"Eur J Haematol"},{"issue":"5","key":"10.1053\/j.seminhematol.2026.04.004_bib0064","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.bbmt.2016.01.026","article-title":"A reduced-intensity conditioning regimen for patients with dyskeratosis congenita undergoing hematopoietic stem cell transplantation","volume":"22","author":"Nelson","year":"2016","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"issue":"2","key":"10.1053\/j.seminhematol.2026.04.004_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbmt.2013.12.266","article-title":"A prospective trial of minimal intensity conditioning with fludarabine and anti-CD52 antibody alone in dyskeratosis congenita","volume":"20","author":"Lehmann","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"23","key":"10.1053\/j.seminhematol.2026.04.004_bib0066","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.2169\/internalmedicine.55.7462","article-title":"Fatal hemorrhagic gastrointestinal angioectasia after bone marrow transplantation for dyskeratosis congenita","volume":"55","author":"Imai","year":"2016","journal-title":"Intern Med"},{"issue":"9","key":"10.1053\/j.seminhematol.2026.04.004_bib0067","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1038\/sj.bmt.1705839","article-title":"Late death after unrelated-BMT for dyskeratosis congenita following conditioning with alemtuzumab, fludarabine and melphalan","volume":"40","author":"Amarasinghe","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"8","key":"10.1053\/j.seminhematol.2026.04.004_bib0068","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.bbmt.2013.05.021","article-title":"Outcomes of allogeneic hematopoietic cell transplantation in patients with dyskeratosis congenita","volume":"19","author":"Gadalla","year":"2013","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"}],"container-title":["Seminars in Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000302?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0037196326000302?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T17:54:20Z","timestamp":1781027660000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0037196326000302"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0037196326000302"],"URL":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.04.004","relation":{},"ISSN":["0037-1963"],"issn-type":[{"value":"0037-1963","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of telomere biology disorders in developing countries","name":"articletitle","label":"Article Title"},{"value":"Seminars in Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminhematol.2026.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}